Paternal Perinatal Depression, Anxiety, and Stress and Child Development
July 14, 2025
While maternal perinatal mental health has long been a focus of res...
Read More
Lithium Versus Quetiapine Augmentation For Treatment-Resistant Depression
July 8, 2025
A major randomized controlled trial compared the long-term clinical...
Read More
New Study Links Psychiatric Medications to Increased Risk of Amyotrophic Lateral Sclerosis
July 6, 2025
A recent study reveals a notable association between the use of com...
Read More
Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings
July 3, 2025
A comprehensive systematic review reexamines the long-term conseque...
Read More
Benzgalantamine Approved For The Treatment Of Mild-To-Moderate Alzheimer’s Disease
June 27, 2025
The FDA has approved benzgalantamine, a novel oral prodrug of galan...
Read More
Fremanezumab Offers Dual Relief for Patients with Migraine and Major Depression
June 23, 2025
A growing body of evidence highlights the complex bidirectional rel...
Read More
Esketamine Combinations in TRD: SNRI vs SSRI Outcomes
June 20, 2025
In a large real-world comparative effectiveness study involving ove...
Read More
Psilocybin and Escitalopram Show Distinct Brain Effects in Depression Treatment
June 11, 2025
A new randomized controlled trial directly compared the brain effec...
Read More
Stimulant Medication Use and Risk of Psychotic Experiences
June 5, 2025
Recent post marketing surveillance and observational studies have s...
Read More
Valbenazine in Elderly Adults with Tardive Dyskinesia
June 3, 2025
The use of antipsychotics in geriatric patients is complicated by t...
Read More
Comparative Cardiovascular Safety of ADHD Medications
May 29, 2025
Concerns about the cardiovascular safety of medications used for th...
Read More
FDA Clears First Blood Test Used In Diagnosing Alzheimer’s Disease
May 28, 2025
The FDA has approved the first blood-based test to help diagnose Al...
Read More